Detailed Information on Publication Record
2014
Different Clinical Utility of Oropharyngeal Bacterial Screening prior to Percutaneous Endoscopic Gastrostomy in Oncological and Neurological Patients
KROUPA, Radek, Jana JURÁNKOVÁ, Milan DASTYCH, Michal ŠENKYŘÍK, Tomáš PAVLÍK et. al.Basic information
Original name
Different Clinical Utility of Oropharyngeal Bacterial Screening prior to Percutaneous Endoscopic Gastrostomy in Oncological and Neurological Patients
Authors
KROUPA, Radek (203 Czech Republic, guarantor, belonging to the institution), Jana JURÁNKOVÁ (203 Czech Republic, belonging to the institution), Milan DASTYCH (203 Czech Republic, belonging to the institution), Michal ŠENKYŘÍK (203 Czech Republic), Tomáš PAVLÍK (203 Czech Republic, belonging to the institution), Jitka PROKEŠOVÁ (203 Czech Republic, belonging to the institution), Markéta JEČMENOVÁ (203 Czech Republic, belonging to the institution), Jiří DOLINA (203 Czech Republic, belonging to the institution) and Aleš HEP (203 Czech Republic, belonging to the institution)
Edition
BioMed Research International, New York, Hindawi Publishing Corporation, 2014, 2314-6133
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
Biotechnology and bionics
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 1.579
RIV identification code
RIV/00216224:14110/14:00078532
Organization unit
Faculty of Medicine
UT WoS
000344286300001
Keywords in English
RESISTANT STAPHYLOCOCCUS-AUREUS; RANDOMIZED CONTROLLED-TRIAL; ANTIBIOTIC-PROPHYLAXIS; SITE INFECTION; RISK-FACTORS; GASTROINTESTINAL ENDOSCOPY; PERISTOMAL INFECTION; TUBE INSERTION; COMPLICATIONS; COLONIZATION
Tags
Tags
International impact, Reviewed
Změněno: 20/1/2015 13:43, Soňa Böhmová
Abstract
V originále
Background. The aim of this study was to monitor oropharyngeal bacterial colonization in patients indicated for percutaneous endoscopic gastronomy (PEG). Methods. Oropharyngeal swabs were obtained from patients prior to PEG placement. A development of peristomal infection was evaluated. The analysis of oropharyngeal and peristomal site pathogens was done. Results. Consecutive 274 patients referred for PEG due to neurological disorder or cancer completed the study. Oropharyngeal colonization with pathogens was observed in 69%(190/274), dominantly in the neurologic subgroup of patients (P < 0.001). Peristomal infection occurred in 30 (10.9%) of patients and in 57% of them the correlation between oropharyngeal and peristomal agents was present. The presence of oropharyngeal pathogens was assessed as an important risk factor for the development of peristomal infection only in oncological patients (OR = 8.33, 95% CI: 1.66-41.76). Despite a high prevalence of pathogens in neurological patients, it did not influence the risk of peristomal infection with the exception for methicillin resistant Staphylococcus aureus (MRSA) carriers (OR 4.5, 95% CI: 1.08-18.76). Conclusion. During oropharyngeal microbial screening prior to the PEG insertion, the detection of pathogens may be a marker of the increased risk of peristomal infection in cancer patients only. In neurological patients the benefit of the screening is limited to the detection of MRSA carriers.